RE: 10p by year end....:)11 Jan 2019 09:15
Biologic drugs represented eight out of ten top selling drugs in 2016, with expected revenues in 2019 of c$445Bn. Revenues are c$15Bn from the top eight suppliers of manufacturing equipment into this industry.
Biologic manufacture demands real-time analysis throughout the entire process. The Microsaic MiD® ProteinID provides real time analysis from the raw in-coming goods, to upstream 'in-cell' drug production, and subsequent downstream product purification.
The Microsaic MiD® ProteinID was ranked among the top innovative products of the year by The Analytical Scientist Innovation Awards in December 2018.